Snark BidCo, a company controlled by Altor Fund V (No. 1) and Altor Fund V (No. 2) announced a publi…
Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm,…
Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Mark…
Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a missi…
Vinge has advised Terranor Group AB (publ) (“Terranor”) connection with its listing on Nasdaq First…
Vinge has advised Studentbostäder i Norden AB (publ), a real estate company whose shares are listed…
Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. Th…
Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray…
Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, P…
Vinge has advised Tobii AB (publ) in connection with a fully guaranteed rights issue of ordinary sha…
Vinge has advised Cell Impact AB (publ) in connection with a partly guaranteed rights issue which wi…
